NSEPress Release4d ago · 18 Sept 2026, 11:05 am

Press Release

QMS Medical Allied Services Limited · QMSMEDI

✦ AI Summary▲ PositiveM&A

QMS Medical Allied Services Ltd has completed the 100% acquisition of Saarathi Healthcare Pvt Ltd, making it a wholly owned subsidiary. The acquisition will boost QMS MAS's services portfolio and strengthen its presence in the healthcare services and patient management segment.

Analysis Scores

Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment9/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

QMS Medical Allied Services Limited has informed the Exchange regarding a press release dated September 18, 2026, titled "QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare Pvt Ltd.".

Attachments (1)

📄

QMS_18092026110527_SdNSEPressReleaseIntimation.pdf

pdf

Download →
View document text
National Stock Exchange of India Ltd. Exchange Plaza, C 1, Block G, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051. Company Symbol: QMSMEDI ISIN: INE0FMW01018 Sub: Press Release – QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare Pvt Ltd. Pursuant to Regulation 30 of the SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, enclosed herewith the copy of the Press Release which will be given with regard to QMS Medical Allied Services Ltd completes 100% Acquisition of Saarathi Healthcare Pvt Ltd. A copy of the press release is also uploaded on the Company's website. https://qmsmas.com/ Kindly take the same on your records and oblige. Thanking you, Yours truly, FOR QMS MEDICAL ALLIED SERVICES LIMITED TORAL BHADRA COMPANY SECRETARY AND COMPLIANCE OFFICER MEMBERSHIP NO.: A56927 DATE: SEPTEMBER 18, 2026 PLACE: MUMBAI CIN: L33309MH2017PLC299748; Email Id: mm@qmsmas.com QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare Pvt Ltd Mumbai, September 18, 2026: QMS Medical Allied Services Ltd (QMS MAS) has completed the 100% acquisition of Saarathi Healthcare Pvt Ltd, making it a wholly owned subsidiary of the company. The move marks an important step in QMS MAS’s strategy to build an integrated healthcare services platform spanning patient screening, early diagnosis, disease management and patient engagement. QMS MAS began its acquisition journey with Saarathi Healthcare in June 2024 with a 51% stake, which was subsequently increased to 76% in October 2025. With the acquisition of the remaining 24% stake, QMS MAS now holds 100% ownership of Saarathi Healthcare. The complete acquisition will significantly boost QMS MAS’s services portfolio and further strengthen its presence in the healthcare services and patient management segment. QMS MAS specialises in patient screening services through innovative Patient Service Programs (PSP) and the supply of diagnostic medical devices, enabling access to advanced diagnostic testing and supporting early intervention and preventive healthcare. Saarathi Healthcare brings complementary capabilities across disease management, early diagnosis and screening through point-of-care devices, disease awareness and access programmes across therapies. Its model combines digital tools with physical patient engagement, enabling healthcare programmes across different stages of the patient journey. Commenting on the acquisition, Mr Mahesh Makhija, CMD, QMS Medical Allied Services Ltd, said, “The 100% acquisition of Saarathi Healthcare marks an important milestone in our journey towards building a comprehensive and integrated healthcare services platform. By bringing together QMS MAS’s strengths in patient screening and diagnostics with Saarathi’s capabilities in disease management and patient engagement, we aim to provide a more connected continuum of care. Full ownership will enable us to drive deeper integration, strengthen operational synergies and create greater value for patients, healthcare partners and stakeholders.” As part of the transaction, QMS MAS acquired the balance 24% equity stake comprising 1,98,000 shares for a cash consideration of ₹14.225 crore, increasing its shareholding in Saarathi Healthcare from 76% to 100%. The 100% acquisition of Saarathi Healthcare further strengthens QMS MAS’s broader strategy of building an integrated healthcare platform spanning early detection, patient screening, disease management and sustained patient engagement. The development also comes amid a period of accelerated growth for QMS MAS. In June 2026, the company migrated to the NSE Mainboard, while more recently it entered into a five- year exclusive agreement with Germany-based HEINE Optotechnik for the marketing and distribution of its primary diagnostic instruments in India. With a scalable product vertical and a growing healthcare services portfolio as its two key growth engines, QMS MAS has set an ambitious target of surpassing the ₹500 crore revenue milestone by FY29. About QMS Medical Allied Services Ltd QMS Medical Allied Services Ltd (QMS MAS) is an integrated healthcare solutions company operating across healthcare products and services. The company provides capabilities spanning patient engagement, Patient Service Programs (PSPs), disease management, preventive healthcare initiatives, patient screening and medical camps, healthcare staffing, and medical and diagnostic solutions. Through its integrated healthcare approach, QMS supports pharmaceutical companies, healthcare providers, and patients by improving patient access, enabling continuity of care, and enhancing healthcare outcomes. Leveraging a combination of healthcare expertise, digital capabilities, and scalable service models, QMS continues to strengthen its role across the evolving healthcare ecosystem. For Media Queries: Name: Deepali Shah Mob. No.: 9029557708 Email Id: deepali@fortunapr.com